Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Illness Perceptions and Heath Related Quality of Life in Patients with Primary Immune Thrombocytopenia

Christina E Lekarakou, Antonios Bertsias, Panagiotis T Diamantopoulos, Marina Mantzourani, Anthi Bouchla, Sofia Chatzileontiadou, Peggy Kanellou, Athanasios Gakopoulos, George Katrinakis, Maria Psyllaki, Vasiliki Pappa, Maria Papaioannou, Dimitra Liapi, Sosana Delimpasi, Helen A Papadaki, George Koulierakis, Charalampos G Pontikoglou

Blood (2024) 144 (Supplement 1): 7692.

https://doi.org/10.1182/blood-2024-204552

Published: 2024

Journal Articles

Nationwide Multicenter Real-World Survey of CAR-T Cell Toxicity Prophylactic and Treatment Management Strategies

Blood (2024) 144 (Supplement 1): 7764.

https://doi.org/10.1182/blood-2024-194885

Published: 2024

Journal Articles

The Prognostic Significance of Serum β 2 - Microglobulin Levels (sβ 2 m) in Diffuse Large B-Cell Lymphoma (DLBCL)

Blood (2024) 144 (Supplement 1): 6476.

https://doi.org/10.1182/blood-2024-210185

Published: 2024

Journal Articles

Myeloid-Derived Suppressor Cells As Novel Biomarkers in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Irene Mavroudi, Nikoleta Bizymi, Ioanna Voulgari, Athina Damianaki, Erasmia Boutakoglou, Vasileia Kaliafentaki, Peggy Kanellou, Anna Kolovou, Sofia Chatzileontiadou, Maria Papaioannou, Helen A Papadaki

Blood (2024) 144 (Supplement 1): 6762.

https://doi.org/10.1182/blood-2024-207080

Published: 2024

Journal Articles

Malignant Transformation in Relationship to Clonal Hematopoiesis in CIN

Grigorios Tsaknakis, Erasmia Boutakoglou, Stavros Papadakis, Irene Mavroudi, Anna Maria Perantonaki, Peggy Kanellou, Helen A Papadaki

Blood (2024) 144 (Supplement 1): 2529.

https://doi.org/10.1182/blood-2024-206786

Published: 2024

Journal Articles

Heterogeneous Genetic Landscape of Chronic Idiopathic Neutropenia Revealed By Whole Exome Sequencing

Grigorios Tsaknakis, Alice Grossi, Marta Rusmini, Isabella Ceccherini, Paolo Uva, Maurizio Miano, Irene Mavroudi, Erasmia Boutakoglou, Carlo Dufour, Francesca Fioredda, Helen A. Papadaki

Blood (2023) 142 (Supplement 1): 931.

https://doi.org/10.1182/blood-2023-179736

Published: 2023

Journal Articles

Investigation of Neutrophil Extracellular Trap (NET) Induction in Patients with Chronic Idiopathic Neutropenia Bearing Mutations in the Mediterranean Fever ( MEFV ) Gene

Iris Karkempetzaki, Irene Mavroudi, Grigorios Tsaknakis, Dimitra Nikoleri, Spiros Georgakis, George Bertsias, George Goulielmos, Akrivi Chrysanthopoulou, Panagiotis Skendros, Konstantinos Ritis, Helen A. Papadaki

Blood (2022) 140 (Supplement 1): 5479–5480.

https://doi.org/10.1182/blood-2022-167146

Published: 2022

Journal Articles

Assessment of the Frequency of Variants of Undetermined Significance (VUS) in Adult Patients with Chronic Idiopathic Neutropenia Studied for Myeloid Gene Mutations By Next Generation Sequencing

Grigorios Tsaknakis, Irene Mavroudi, Erasmia Boutakoglou, Helen A. Papadaki

Blood (2022) 140 (Supplement 1): 11164.

https://doi.org/10.1182/blood-2022-166190

Published: 2022

Journal Articles

Follow-up Next Generation Sequencing (NGS) Analyses on Clonal Chronic Idiopathic Neutropenia (CIN) Patients: Insights in the Natural History of the Disease

Grigorios Tsaknakis, Stavros Papadakis, Peggy Kanellou, Irene Mavroudi, Irene Fragiadaki, Charalampos Pontikoglou, Anna Gallì, Luca Malcovati, Helen A. Papadaki

Blood (2021) 138 (Supplement 1): 987.

https://doi.org/10.1182/blood-2021-151131

Published: 2021

Journal Articles

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

Blood (2021) 138 (Supplement 1): 1535.

https://doi.org/10.1182/blood-2021-149630

Published: 2021

Journal Articles

Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever ( MEFV ) in a Cohort of Patients with Chronic Idiopathic Neutropenia

Panagiotis Skendros, Irene Mavroudi, Stavros Papadakis, Peggy Kanellou, Erasmia Boutakoglou, Grigorios Tsaknakis, Charalampos Pontikoglou, George Goulielmos, Konstantinos Ritis, Helen A. Papadaki

Blood (2021) 138 (Supplement 1): 3124.

https://doi.org/10.1182/blood-2021-150072

Published: 2021

Journal Articles

The Experience of the Cooperation in Science and Technology European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (COST EuNet-INNOCHRON) Action and the Sweden Experience in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Era

Michail Spanoudakis, David C. Dale, Emily Tran, Marije Bartels, Suncica Kapor, Daniela Guardo, Jelena Roganovic, Joanne Yacobovich, Christer Nilsson, Carlo Dufour, Helen A. Papadaki, Jan Palmblad

Blood (2021) 138 (Supplement 1): 3125.

https://doi.org/10.1182/blood-2021-150486

Published: 2021

Journal Articles

Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia

Grigorios Tsaknakis, Anna Gallì, Stavros Papadakis, Peggy Kanellou, Chiara Elena, Gabriele Todisco, Elisa Bono, Ettore Rizzo, Elisabetta Molteni, Irene Fragiadaki, Irene Mavroudi, Charalampos Pontikoglou, Anastasios Batas, Stella Maxouri, Emmanouela Linardaki, Nektarios Tavernarakis, Luca Malcovati, Helen A. Papadaki

Blood (2021) 138 (14): 1249–1257.

https://doi.org/10.1182/blood.2021010815

Published: 2021

Includes: Supplemental data

Journal Articles

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Blood (2020) 136 (Supplement 1): 33–35.

https://doi.org/10.1182/blood-2020-138390

Published: 2020

Journal Articles

Frequency and Functional Analysis of Myeloid-Derived Suppressor Cells (MDSCs) in the Peripheral Blood and Bone Marrow of Patients with Chronic Idiopathic Neutropenia (CIN)

Nikoleta Bizymi, MD MSc, Athina Damianaki, Maria Velegraki, MD PhD, Konstantina Zavitsanou, MSc, Anastasios Karasachinidis, Anthie Georgopoulou, PhD, Irene Mavroudi, PhD, John Sperelakis, MD, George Kontakis, MD PhD, Charalampos Pontikoglou, MD PhD, Helen A. Papadaki, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-136500

Published: 2020

Journal Articles

Estimated Glomerular Filtration Rate Is an Independent Predictor of Outcome in High-Risk Myelodysplastic Syndrome (MDS) and Low Blast Count Acute Myeloid Leukaemia (AML) Patients Treated with Azacytidine (AZA). a Retrospective Study from the MDS Registry of the Hellenic MDS Study Group

Blood (2019) 134 (Supplement_1): 5423.

https://doi.org/10.1182/blood-2019-125806

Published: 2019

Journal Articles

The Prognostic Significance of Monocytopenia in Patients with Myelodysplastic Syndrome

Panagiotis T Diamantopoulos, MD PhD, Vassiliki Pappa, MD, Nora-Athina Viniou, MD PhD, Ioannis Kotsianidis, Alexandra Kourakli, MD PhD, Argiris Symeonidis, MD PhD, Sotirios Papageorgiou, MD PhD, Elena E. Solomou, MD, Anastasia Pouli, MD PhD, Panagiotis Panagiotidis, MD PhD, Maria Dimou, MD PhD, Kalliopi Zafeiropoulou, Stamatis J. Karakatsanis, MD MSc, Anna Vardi, MD PhD, Theodoros P. Vassilakopoulos, MD PhD, Dimitrios Tsokanas, George Drakos, Spyros Hontropoulos, Eleftheria Hatzimichael, Aikaterini Megalakaki, Panagiotis Repousis, MD, Maria Kotsopoulou, Georgia Kaiafa, MD, Menelaos Konstantinos Papoutselis, Anastasia Sioni, Nikolaos Charchalakis, PhD, Eleni Bouronikou, Georgios Vasilopoulos, Vasileios Lazaris, Maria Spiliotopoulou, Flora Kontopidou, Christos K. Kontos, PhD, Stamatina Kalyva, Apostolos Hatzitolios, Helen A. Papadaki, MD PhD, Achilles Anagnostopoulos, Nikolaos Anagnostopoulos, Athanasios Galanopoulos, MD PhD

Blood (2019) 134 (Supplement_1): 5427.

https://doi.org/10.1182/blood-2019-127417

Published: 2019

Journal Articles

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Elena E. Solomou, MD, Alexandra Kourakli, MD PhD, Anna Vardi, MD PhD, Ioannis Kotsianidis, MD PhD, Panagiotis Zikos, MD, Vassiliki Pappa, MD, Athanasios Galanopoulos, MD PhD, Aikaterini Palla, Athina Vyniou, Charalampos Pontikoglou, MD PhD, Panagiotis T Diamantopoulos, MD PhD, Theodoros Vassilakopoulos, MD, Aikaterini Megalakaki, Eleni Variami, Helen A. Papadaki, MD PhD, George Vassilopoulos, MD PhD, Achilles Anagnostopoulos, Argiris Symeonidis, MD PhD

Blood (2019) 134 (Supplement_1): 5417.

https://doi.org/10.1182/blood-2019-131003

Published: 2019

Journal Articles

Prognostic Significance of Severe Thrombocytopenia in Overall Survival of Patients with Myelodysplastic Syndromes Treated with Azacytidine. a Multicenter Study By the Hellenic MDS Study Group

Athanasios Galanopoulos, MD PhD, Evdoxia Kamouza, Christos K. Kontos, PhD, Argiris Symeonidis, MD PhD, Vassiliki Pappa, MD, Alexandra Kourakli, MD PhD, Nora-Athina Viniou, MD, Sotirios Papageorgiou, MD PhD, Charalampos Pontikoglou, Menelaos Konstantinos Papoutselis, Helen A. Papadaki, MD PhD, Eleftheria Hatzimichael, Panagiotis Zikos, Dr, Maria Dimou, Panayiotis Panayiotidis, MD PhD, Dimitrios Tsokanas, Despina Mparmparousi, Flora Kontopidou, Eleni Variami, Panagiotis Repousis, MD, Elias Poulakidas, Dimitrios Christoulas, MD, Theodoros Vassilakopoulos, MDPhD, Michael Voulgarelis, MD PhD, Aikaterini Megalakaki, Maria Kotsopoulou, Giorgos Karianakis, Despina Kaliontzi, Ioannis Adamopoulos, MD, Maria Dalekou, Anastasia Sioni, Maria Papaioannou, Dimitrios Gogos, Panagiotis Theodorou Diamantopoulos, MD PhD, Elena E. Solomou, MD, Ioannis Kotsianidis, PhD

Blood (2018) 132 (Supplement 1): 1822.

https://doi.org/10.1182/blood-2018-99-119531

Published: 2018

Journal Articles

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Blood (2018) 132 (6): 666–670.

https://doi.org/10.1182/blood-2018-02-833608

Published: 2018

NARROW

Illness Perceptions and Heath Related Quality of Life in Patients with Primary Immune Thrombocytopenia

Nationwide Multicenter Real-World Survey of CAR-T Cell Toxicity Prophylactic and Treatment Management Strategies

The Prognostic Significance of Serum β 2 - Microglobulin Levels (sβ 2 m) in Diffuse Large B-Cell Lymphoma (DLBCL)

Myeloid-Derived Suppressor Cells As Novel Biomarkers in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Malignant Transformation in Relationship to Clonal Hematopoiesis in CIN

Heterogeneous Genetic Landscape of Chronic Idiopathic Neutropenia Revealed By Whole Exome Sequencing

Investigation of Neutrophil Extracellular Trap (NET) Induction in Patients with Chronic Idiopathic Neutropenia Bearing Mutations in the Mediterranean Fever ( MEFV ) Gene

Assessment of the Frequency of Variants of Undetermined Significance (VUS) in Adult Patients with Chronic Idiopathic Neutropenia Studied for Myeloid Gene Mutations By Next Generation Sequencing

Follow-up Next Generation Sequencing (NGS) Analyses on Clonal Chronic Idiopathic Neutropenia (CIN) Patients: Insights in the Natural History of the Disease

Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)

Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever ( MEFV ) in a Cohort of Patients with Chronic Idiopathic Neutropenia

The Experience of the Cooperation in Science and Technology European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (COST EuNet-INNOCHRON) Action and the Sweden Experience in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Era

Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia

Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study

Frequency and Functional Analysis of Myeloid-Derived Suppressor Cells (MDSCs) in the Peripheral Blood and Bone Marrow of Patients with Chronic Idiopathic Neutropenia (CIN)

Estimated Glomerular Filtration Rate Is an Independent Predictor of Outcome in High-Risk Myelodysplastic Syndrome (MDS) and Low Blast Count Acute Myeloid Leukaemia (AML) Patients Treated with Azacytidine (AZA). a Retrospective Study from the MDS Registry of the Hellenic MDS Study Group

The Prognostic Significance of Monocytopenia in Patients with Myelodysplastic Syndrome

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

Prognostic Significance of Severe Thrombocytopenia in Overall Survival of Patients with Myelodysplastic Syndromes Treated with Azacytidine. a Multicenter Study By the Hellenic MDS Study Group

Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only